Ala. Man Says Eli Lilly Fraudulently Advertised Zyprexa

MONTGOMERY, Ala. - An Alabama man sued Eli Lilly & Co. on Sept. 12, accusing the company of fraudulently advertising its antipsychotic drug Zyprexa. Speaks v. Eli Lilly & Co. No. 2:05-cv-00873 (M.D. Ala.).

Forest Speaks sued Eli Lilly & Co. in the U.S. District Court for the Middle District of Alabama, claiming the manufacturer's antipsychotic drug Zyprexa (olanzapine) caused him unspecified injuries. He seeks recovery for violation of Alabama's Extended Manufacturer's Liability Doctrine, strict products liability for failure to warn and for a defective product, negligence, breach of express and implied warranties, fraud, fraud by concealment, unjust enrichment and …